Insider · CIK 0002038400
Josiah Craver
Files at FTH (Sensei Biotherapeutics, Inc.). First filing -, latest -.
In brief
Josiah Craver files SEC Form 4 as officer at FTH (Sensei Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Josiah Craver has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Performance-Based Stock Option (right to buy)derivative | +30,824 | $0.00 | $0 | 30,824 | Jul 23, 2026 |
| Apr 10, 2026 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Apr 14, 2026 |
| Feb 14, 2025 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 14, 2025 |
| Dec 20, 2024 | FTH Sensei Biotherapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Dec 23, 2024 |
Questions about Josiah Craver
Answered from the filings on this page, as of the latest one.
Is Josiah Craver buying or selling?
Josiah Craver has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Josiah Craver's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Josiah Craver has 0.
Where does Josiah Craver file Form 4?
Josiah Craver has filed Form 4 at FTH (Sensei Biotherapeutics, Inc.) as PAO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.